1. ALLA AKTIER
  2. NYHETER
  3. Q-LINEA

Q-Linea

Nyheter Q-Linea Nyheter alla bolag

Q-linea receives request for a 3-year contract at prominent Hospital in Milan, Italy

Q-linea AB (Publ) (OMX: QLINEA) announces that the company has received a formal request for a direct contract (Affidamento Diretto) for an ASTar® system from ASST Grande Ospedale Metropolitano Niguarda.

The Ospedale Niguarda, one of the most prominent Hospitals in Italy, is now completing the internal process and expectations are for the contract to be formalized in the very next few weeks.

The choice of ASTar by the Microbiology Laboratory comes after a multi-vendor evaluation conducted at the beginning of 2024 and has been based on the very positive experience in terms of ease of use, workflow and strong clinical results displayed in the management of critical patients affected by sepsis.

“We are very pleased with this success in another key Italian Institution like Ospedale Niguarda that had the implementation of rAST as one of their key projects for 2024. ASTar continues to be the preferred technical choice in the country, a path we are counting to continue and strengthen going forward” said Franco Pellegrini, VP Sales EMEA at Q-linea.

For more information, please contact:

Stuart Gander, President & CEO, Q-linea
Stuart.Gander@qlinea.com
+1 857 409 7463

Christer Samuelsson, CFO /IR, Q-linea AB
Christer.Samuelsson@qlinea.com
+46 (0) 70-600 15 20

About Q-linea

Q-linea’s rapid AST system, ASTar®, accelerates and simplifies the time-sensitive workflows faced during the treatment of patients with bloodstream infections and sepsis. Hospitals use ASTar to vastly reduce the time to optimal antimicrobial therapies and ensure that patients receive the correct treatments sooner — when time matters most. We are helping to create sustainable healthcare, now and in the future, and safeguard the effectiveness of antibiotics for generations to come.
Q-linea is headquartered in Uppsala, Sweden and has regional offices in Italy and the USA, with partnerships worldwide.
ASTar Instrument and ASTar BC G- Consumable kit are CE-IVD marked and FDA 510(k) cleared. For more information, please visit www.qlinea.com

Attachments

Q-linea receives request for a 3-year contract at prominent Hospital in Milan, Italy

Datum 2024-10-25, kl 11:25
Källa MFN
Bifogade filer
Q-linea receives request for a 3-year contract at prominent Hospital in Milan, Italy
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!